Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-2510-30
Published February 7, 2024 · Recall initiated: January 8, 2024
Summary
FDA records drug Class II recall D-0275-2024, published February 7, 2024 and initiated January 8, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 10,672 30-count bottles; Lot: Lot # 100047273; Exp. 07/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if BUDESONIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUDESONIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- Nationwide
- UPC
- 0305912510303
- Lot
- Lot # 100047273; Exp. 07/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABudesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules perJune 17, 2026
- FDABudesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only,July 30, 2025
- FDACefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,February 7, 2024
- FDABudesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated,February 7, 2024
- FDADiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620January 31, 2024
- FDABudesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single DoseOctober 5, 2022
Questions about this recall
Was Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-2510-30 recalled?
Yes. FDA published recall D-0275-2024 on February 7, 2024. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUDESONIDE. UPC: 0305912510303.